Jeffrey D Chismar

Title: Innovations by Jeffrey D. Chismar in Analyte Quantification

Introduction

Jeffrey D. Chismar is an esteemed inventor based in Plymouth, MN, whose contributions to the field of biotechnology reflect significant advancements in the quantification of analyte polynucleotides. With a portfolio that includes four patents, Chismar has established himself as a valuable figure in the research and development landscape.

Latest Patents

Chismar's latest inventions focus on systems that employ innovative methodologies for the accurate quantification of polynucleotides. His patents include a "Parametric system for quantifying analyte polynucleotides," which utilizes computer-implemented analysis of real-time amplification data, employing a calibration curve defined by parametric equations. Another notable patent is the "Real-time amplification and monitoring system incorporating vector-based algorithm for analyzing polynucleotide-containing samples." This system leverages a computer or processing device with software designed to perform vector analysis of growth curves, simplifying polynucleotide quantitation by eliminating the need for establishing thresholds or calculating derivatives.

Career Highlights

Chismar's career has been significantly marked by his role at Gen-Probe, Inc., where he has been instrumental in developing advanced systems for biological analysis. His innovative approaches have not only contributed to the company's success but have also set new benchmarks in the field of analyte quantification.

Collaborations

Collaboration has been a key aspect of Chismar's work. He has worked alongside notable colleagues such as James M. Carrick and Michael J. Gilly. Through their teamwork, they have been able to leverage their collective expertise, driving forward the boundaries of technology in polynucleotide analysis.

Conclusion

Jeffrey D. Chismar's robust patent portfolio and collaborative efforts exemplify his commitment to enhancing the efficiency and accuracy of analyte quantification. His contributions continue to foster innovation within the biotechnology sector, paving the way for future advancements in the analysis of genetic materials.